1. Pediatric Clinical Pharmacology Training
Bridgette L. Jones, MD MS
Associate Professor Pediatrics, University of Missouri Kansas City
American Academy of Pediatrics
Chair, Committee on Drugs

2. No relevant conflicts of interest

3. NIH T32 Pediatric Clinical Pharmacology Fellowships
Mandated through the BPCA 2007 legislation
Provide training in pediatric clinical pharmacology
Stimulate interdisciplinary collaboration among clinical, translational, and basic researchers in pediatric therapeutics research
Enable the development of a pediatric pharmacology section within the adult clinical pharmacology department
Purpose: help ensure that a diverse and highly trained workforce is available in an area that currently has a limited number of researchers. 

4. Children’s Mercy Pediatric Clinical Pharmacology Training Program
Fully accredited by the American Board of Clinical Pharmacology (ABCP)
Has formally trained 19 fellows since 1999 (pediatricians and clinical pharmacists, one pediatric nurse practitioner)
Training model integrates pediatric clinical pharmacology with a primary pediatric subspecialty
(e.g. Infectious Disease/Clinical Pharmacology, 4 year combined training)

5. Children’s Mercy Pediatric Clinical Pharmacology Training Program

6. Trainee 1 2 3 4 5** 6 7 8 9 10 12 13 Totals completed projects 1515
# completed -basic
# completed -clinical 11
# studies in progress 5 24
# basic studies in progress
# clinical studies in progress 17
# publications 51
# original research publications 22
# scientific presentations 18 66
# peer-reviewed grants funded
NIH-LRP
yes no
DNA
K applied
K awarded
KL2 (CTSA)
KL2
NASPGHAN
* denotes program graduate
** denotes former ASCPT Presidential Trainee Award recipient
DNA denotes "did not apply"
N.B. Jean Dinh, PharmD, PhD entered program in July 2014 and to date, has no academic output while in the program
updated July 2017

7. Former Trainees Jennifer Goldman MD MS, Infectious Disease
KL2
R01 awarded 2018
Adverse Drugs Reactions, Bactrim Toxicity
Jonathon Wagner DO, Cardiology
Statin pharmacotherapeutics
Valentina Shakhnovich, MD
NASPHAGAN career development award
Obesity in PPI pharmacology
Ryan Funk PharmD PhD
Biomarkers/pharmacology of disease modifying drugs in pediatric rheumatic disease

8. Trainings programs address a critical barrier in pediatric drug development
Recognize gaps in knowledge and areas of need
Tools and skillsets to address questions and alleviate barriers to pediatric drug development
Conduct adequate/successful pediatric clinical trials

9. Susan Abdel-Rahman, Program Director
Bridgette L. Jones, Associate Program Director
education/fellowships/pediatric-clinical- pharmacology-fellowship/